Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)

5.62 -0.07 (-1.23%) At close: 03:04PM CST

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Zhengding County High-tech Ind Dev Zone
No. 71, Menglong Street South District Zhengding Area
Shijiazhuang 050800
China
83 311 8919 0181
https://www.heparin.cn

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 1,306

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Xiaodong Gao	GM & Chairman	N/A	N/A	1973
Mr. Wang Jun	CFO & Deputy GM	N/A	N/A	1977
Ms. Zhiying Zhang	Deputy GM & Non-Independent Director	N/A	N/A	1962
Ms. Yunxia Sun	Deputy GM & Non-Independent Director	N/A	N/A	1981

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.

Corporate Governance

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.